Laboratory Corporation of America (LH) Revenue & Revenue Breakdown
Laboratory Corporation of America Revenue Highlights
Latest Revenue (Y)
$12.16B
Latest Revenue (Q)
$3.22B
Main Segment (Y)
Diagnostics
Main Geography (Y)
North America
Laboratory Corporation of America Revenue by Period
Laboratory Corporation of America Revenue by Year
| Date | Revenue | Change |
|---|---|---|
| 2023-12-31 | $12.16B | -18.25% |
| 2022-12-31 | $14.88B | -7.72% |
| 2021-12-31 | $16.12B | 15.33% |
| 2020-12-31 | $13.98B | 20.98% |
| 2019-12-31 | $11.55B | 1.95% |
| 2018-12-31 | $11.33B | 8.54% |
| 2017-12-31 | $10.44B | 8.29% |
| 2016-12-31 | $9.64B | 11.08% |
| 2015-12-31 | $8.68B | 44.39% |
| 2014-12-31 | $6.01B | 3.50% |
| 2013-12-31 | $5.81B | 2.41% |
| 2012-12-31 | $5.67B | 2.33% |
| 2011-12-31 | $5.54B | 10.76% |
| 2010-12-31 | $5.00B | 6.59% |
| 2009-12-31 | $4.69B | 4.21% |
| 2008-12-31 | $4.51B | 10.74% |
| 2007-12-31 | $4.07B | 13.30% |
| 2006-12-31 | $3.59B | 7.91% |
| 2005-12-31 | $3.33B | 7.87% |
| 2004-12-31 | $3.08B | 4.95% |
| 2003-12-31 | $2.94B | 17.21% |
| 2002-12-31 | $2.51B | 14.00% |
| 2001-12-31 | $2.20B | 14.61% |
| 2000-12-31 | $1.92B | 12.99% |
| 1999-12-31 | $1.70B | 5.34% |
| 1998-12-31 | $1.61B | 6.16% |
| 1997-12-31 | $1.52B | -5.52% |
| 1996-12-31 | $1.61B | 12.27% |
| 1995-12-31 | $1.43B | 64.13% |
| 1994-12-31 | $872.50M | 14.73% |
| 1993-12-31 | $760.50M | - |
Laboratory Corporation of America generated $12.16B in revenue during NA 2023, up -18.25% compared to the previous quarter, and up 107.31% compared to the same period a year ago.
Laboratory Corporation of America Revenue by Quarter
| Date | Revenue | Change |
|---|---|---|
| 2024-06-30 | $3.22B | 1.39% |
| 2024-03-31 | $3.18B | 4.72% |
| 2023-12-31 | $3.03B | -0.77% |
| 2023-09-30 | $3.06B | 0.76% |
| 2023-06-30 | $3.03B | -19.70% |
| 2023-03-31 | $3.78B | 2.82% |
| 2022-12-31 | $3.67B | 1.89% |
| 2022-09-30 | $3.61B | -2.46% |
| 2022-06-30 | $3.70B | -5.20% |
| 2022-03-31 | $3.90B | -3.86% |
| 2021-12-31 | $4.06B | -0.16% |
| 2021-09-30 | $4.06B | 5.78% |
| 2021-06-30 | $3.84B | -7.71% |
| 2021-03-31 | $4.16B | -7.31% |
| 2020-12-31 | $4.49B | 15.24% |
| 2020-09-30 | $3.90B | 40.71% |
| 2020-06-30 | $2.77B | -1.95% |
| 2020-03-31 | $2.82B | -4.39% |
| 2019-12-31 | $2.95B | 0.85% |
| 2019-09-30 | $2.93B | 1.62% |
| 2019-06-30 | $2.88B | 3.24% |
| 2019-03-31 | $2.79B | 0.13% |
| 2018-12-31 | $2.79B | -1.55% |
| 2018-09-30 | $2.83B | -1.22% |
| 2018-06-30 | $2.87B | 0.63% |
| 2018-03-31 | $2.85B | 1.86% |
| 2017-12-31 | $2.80B | 5.31% |
| 2017-09-30 | $2.66B | 4.42% |
| 2017-06-30 | $2.54B | 3.92% |
| 2017-03-31 | $2.45B | 0.77% |
| 2016-12-31 | $2.43B | 0.57% |
| 2016-09-30 | $2.41B | -0.66% |
| 2016-06-30 | $2.43B | 2.65% |
| 2016-03-31 | $2.37B | 2.19% |
| 2015-09-30 | $2.32B | 2.12% |
| 2015-06-30 | $2.27B | 26.54% |
| 2015-03-31 | $1.79B | 18.54% |
| 2014-12-31 | $1.51B | -2.52% |
| 2014-09-30 | $1.55B | 2.33% |
| 2014-06-30 | $1.52B | 5.99% |
| 2014-03-31 | $1.43B | -0.44% |
| 2013-12-31 | $1.44B | -1.72% |
| 2013-09-30 | $1.46B | -0.41% |
| 2013-06-30 | $1.47B | 1.89% |
| 2013-03-31 | $1.44B | 2.53% |
| 2012-12-31 | $1.41B | -0.99% |
| 2012-09-30 | $1.42B | -0.28% |
| 2012-06-30 | $1.42B | 0.01% |
| 2012-03-31 | $1.42B | 4.19% |
| 2011-12-31 | $1.37B | -2.73% |
| 2011-09-30 | $1.40B | 0.09% |
| 2011-06-30 | $1.40B | 2.55% |
| 2011-03-31 | $1.37B | 5.64% |
| 2010-12-31 | $1.30B | 1.48% |
| 2010-09-30 | $1.28B | 3.08% |
| 2010-06-30 | $1.24B | 3.75% |
| 2010-03-31 | $1.19B | 2.45% |
| 2009-12-31 | $1.17B | -1.69% |
| 2009-09-30 | $1.19B | -0.31% |
| 2009-06-30 | $1.19B | 2.86% |
| 2009-03-31 | $1.16B | 3.27% |
| 2008-12-31 | $1.12B | -1.41% |
| 2008-09-30 | $1.14B | -1.11% |
| 2008-06-30 | $1.15B | 4.04% |
| 2008-03-31 | $1.10B | 9.68% |
| 2007-12-31 | $1.01B | - |
Laboratory Corporation of America generated $3.22B in revenue during Q1 2024, up 1.39% compared to the previous quarter, and up 85.26% compared to the same period a year ago.
Laboratory Corporation of America Revenue Breakdown
Laboratory Corporation of America Revenue Breakdown by Product
Annual Revenue by Product
| Product/Service | Dec 22 | Dec 21 | Dec 19 | Dec 18 |
|---|---|---|---|---|
| Drug Development | $5.71B | $11.69B | - | - |
| Diagnostics | $9.20B | $20.73B | - | - |
| Covance Drug Development | - | - | $4.58B | $4.31B |
| LabCorp Diagnostics | - | - | $7.00B | $7.03B |
Laboratory Corporation of America's latest annual revenue breakdown by segment (product or service), as of Dec 22: Diagnostics (61.71%), and Drug Development (38.29%).
Quarterly Revenue by Product
| Product/Service | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 |
|---|---|---|---|---|---|
| LabCorp Diagnostics | $2.52B | $2.48B | - | - | - |
| Covance Drug Development | $707.00M | $710.90M | - | - | - |
| Drug Development | - | $710.90M | $2.77B | $719.10M | $699.00M |
| Diagnostics | - | $2.48B | $9.42B | $2.34B | $2.34B |
Laboratory Corporation of America's latest quarterly revenue breakdown by segment (product or service), as of Jun 24: LabCorp Diagnostics (78.12%), and Covance Drug Development (21.88%).
Laboratory Corporation of America Revenue Breakdown by Country
Annual Revenue by Country
| Country | Dec 21 | Dec 20 | Dec 19 | Dec 18 |
|---|---|---|---|---|
| North America | $13.09B | $11.53B | - | - |
| Europe | $2.05B | $1.51B | - | - |
| Other countries | $976.40M | $941.00M | $1.20B | $1.18B |
Laboratory Corporation of America's latest annual revenue breakdown by geography, as of Dec 21: North America (81.22%), Europe (12.72%), and Other countries (6.06%).
Quarterly Revenue by Country
| Country | Jun 24 | Mar 24 | Sep 23 | Jun 23 |
|---|---|---|---|---|
| UNITED STATES | $2.70B | $2.65B | $2.55B | $2.54B |
Laboratory Corporation of America's latest quarterly revenue breakdown by geography, as of Jun 24: UNITED STATES (100.00%).
Laboratory Corporation of America Peer Comparison by Revenue
LH Revenue FAQ
What is Laboratory Corporation of America’s yearly revenue?
Laboratory Corporation of America's yearly revenue for 2023 was $12.16B, representing a decrease of -18.25% compared to 2022. The company's yearly revenue for 2022 was $14.88B, representing a decrease of -7.72% compared to 2021. LH's yearly revenue for 2021 was $16.12B, representing an increase of 15.33% compared to 2020.
What is Laboratory Corporation of America’s quarterly revenue?
Laboratory Corporation of America's quarterly revenue for Q1 2024 was $3.22B, a 1.39% increase from the previous quarter (Q4 2023), and a 6.17% increase year-over-year (Q1 2023). The company's quarterly revenue for Q4 2023 was $3.18B, a 4.72% increase from the previous quarter (Q3 2023), and a -15.92% decrease year-over-year (Q4 2022). LH's quarterly revenue for Q3 2023 was $3.03B, a -0.77% decrease from the previous quarter (Q2 2023), and a -17.44% decrease year-over-year (Q3 2022).
What is Laboratory Corporation of America’s revenue growth rate?
Laboratory Corporation of America's revenue growth rate for the last 3 years (2021-2023) was -24.56%, and for the last 5 years (2019-2023) was 5.25%.
What are Laboratory Corporation of America’s revenue streams?
Laboratory Corporation of America's revenue streams in c 22 are Drug Development, and Diagnostics. Drug Development generated $5.71B in revenue, accounting 38.29% of the company's total revenue, down -51.16% year-over-year. Diagnostics generated $9.2B in revenue, accounting 61.71% of the company's total revenue, down -55.60% year-over-year.
What is Laboratory Corporation of America’s main source of revenue?
For the fiscal year ending Dec 22, the largest source of revenue of Laboratory Corporation of America was Diagnostics. This segment made a revenue of $9.2B, representing 61.71% of the company's total revenue.